Zhang Yi, Zhang Li, Zhang Qiyu, Hong Weilong, Lin Xiaohua
Department of Dermatology, the First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325000, China.
Department of Hepatobiliary Surgery, the First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325000, China.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2017 May 25;46(6):609-617. doi: 10.3785/j.issn.1008-9292.2017.12.06.
To explore the effect of microRNA(miR)-222 on cell proliferation and apoptosis of fibroblasts in hypertrophic scar (HS) and the underlying mechanisms. The expression of miR-222 in the HS and the normal skin tissues was detected by real-time RT-PCR. The HS fibroblasts were transfected with miR-222 mimic and miR-222 inhibitor respectively. The cell viability was tested with MTT assay, cell cycle distribution and apoptosis were detected with flow cytometry and the expression levels of proliferation, apoptosis and cell cycle related proteins were determined with Western blot. Direct target of miR-222 was evaluated by dual-luciferase reporter assay. miR-222 was significantly up-regulated in HS tissues compared with normal skin tissues(<0.05). Overexpression of miR-222 enhanced the cell viability of HS fibroblasts; increased mRNA and protein expressions of proliferating cell nuclear antigen (PCNA), collagen alpha-1 (Ⅰ) chain (Col1A1) and collagen alpha-1 (Ⅲ) chain (Col3A1); increased cell population in S phase and protein expressions of cyclin D1, cyclin E1 and cyclin-dependent kinases 1 (CDK1); inhibited cell apoptosis and reduced protein expressions of caspase-3/9. Overexpression of MMP1 attenuated the effects of miR-222 on the cell viability and apoptosis in fibroblasts, reduced expression levels of PCNA, cyclin D1 and the expression of caspase-3 was increased. miR-222 enhances cell proliferation and inhibits cell apoptosis of HS fibroblasts through negative regulation of MMP1, which suggests that miR-222 and MMP1 might be used as novel biomarkers and targets in diagnostic and therapeutic approaches for HS.
探讨微小RNA(miR)-222对增生性瘢痕(HS)成纤维细胞增殖和凋亡的影响及其潜在机制。采用实时逆转录聚合酶链反应(RT-PCR)检测HS组织和正常皮肤组织中miR-222的表达。分别用miR-222模拟物和miR-222抑制剂转染HS成纤维细胞。采用MTT法检测细胞活力,流式细胞术检测细胞周期分布和凋亡情况,蛋白质免疫印迹法检测增殖、凋亡及细胞周期相关蛋白的表达水平。通过双荧光素酶报告基因检测法评估miR-222的直接靶标。与正常皮肤组织相比,HS组织中miR-222显著上调(<0.05)。miR-222过表达增强了HS成纤维细胞的活力;增加了增殖细胞核抗原(PCNA)、Ⅰ型胶原α-1链(Col1A1)和Ⅲ型胶原α-1链(Col3A1)的mRNA和蛋白表达;增加了S期细胞比例以及细胞周期蛋白D1、细胞周期蛋白E1和细胞周期蛋白依赖性激酶1(CDK1)的蛋白表达;抑制了细胞凋亡并降低了半胱天冬酶-3/9的蛋白表达。基质金属蛋白酶1(MMP1)过表达减弱了miR-222对成纤维细胞活力和凋亡的影响,降低了PCNA、细胞周期蛋白D1的表达水平,且半胱天冬酶-3的表达增加。miR-222通过对MMP1的负调控增强HS成纤维细胞的增殖并抑制其凋亡,这表明miR-222和MMP1可能作为HS诊断和治疗新的生物标志物和靶点。